Gene · 3113
Papers2,625
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 2,625
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inhibition of KRAS, MEK and PI3K Demonstrate Synergistic Anti-Tumor Effects in Pancreatic Ductal Adenocarcinoma Cell Lines. | Cancers (Basel) | 2022 | 36139627 | PubTator, text mining | PubMed |
| Gut Non-Bacterial Microbiota: Emerging Link to Irritable Bowel Syndrome. | Toxins (Basel) | 2022 | 36136534 | PubTator, text mining | PubMed |
| Jiyuan oridonin A induces differentiation of acute myeloid leukemia cells including leukemic stem-like cells. | Front Pharmacol | 2022 | 36133825 | PubTator, text mining | PubMed |
| Deciphering the endometrial immune landscape of RIF during the window of implantation from cellular senescence by integrated bioinformatics analysis and machine learning. | Front Immunol | 2022 | 36131919 | PubTator, text mining | PubMed |
| STMN1 as a novel prognostic biomarker in HCC correlating with immune infiltrates and methylation. | World J Surg Oncol | 2022 | 36127700 | PubTator, text mining | PubMed |
| High-throughput sequencing unravels the cell heterogeneity of cerebrospinal fluid in the bacterial meningitis of children. | Front Immunol | 2022 | 36119025 | PubTator, text mining | PubMed |
| Prognostic model based on m6A-associated lncRNAs in esophageal cancer. | Front Endocrinol (Lausanne) | 2022 | 36111294 | PubTator, text mining | PubMed |
| Identification of molecular subtypes in lung adenocarcinoma based on DNA methylation and gene expression profiling-a bioinformatic analysis. | Ann Transl Med | 2022 | 36111050 | PubTator, text mining | PubMed |
| An emerging prognosis prediction model for multiple myeloma: Hypoxia-immune related microenvironmental gene signature. | Front Oncol | 2022 | 36110952 | PubTator, text mining | PubMed |
| Prognostic and immune-related value of complement C1Q (C1QA, C1QB, and C1QC) in skin cutaneous melanoma. | Front Genet | 2022 | 36110204 | PubTator, text mining | PubMed |
| IGF1R signalling is a guardian of self-tolerance restricting autoantibody production. | Front Immunol | 2022 | 36105797 | PubTator, text mining | PubMed |
| MND1 functions as a potential prognostic biomarker associated with cell cycle and immune infiltration in kidney renal clear cell carcinoma. | Aging (Albany NY) | 2022 | 36098680 | PubTator, text mining | PubMed |
| NcRNA-mediated upregulation of CAMK2N1 is associated with poor prognosis and tumor immune infiltration of gastric cancer. | Front Genet | 2022 | 36092901 | PubTator, text mining | PubMed |
| An immunotherapy response prediction model derived from proliferative CD4+ T cells and antigen-presenting monocytes in ccRCC. | Front Immunol | 2022 | 36091022 | PubTator, text mining | PubMed |
| PSMB5 overexpression is correlated with tumor proliferation and poor prognosis in hepatocellular carcinoma. | FEBS Open Bio | 2022 | 36062301 | PubTator, text mining | PubMed |
| Role of spike compensatory mutations in the interspecies transmission of SARS-CoV-2. | One Health | 2022 | 36060458 | PubTator, text mining | PubMed |
| Methamphetamine induces transcriptional changes in cultured HIV-infected mature monocytes that may contribute to HIV neuropathogenesis. | Front Immunol | 2022 | 36059515 | PubTator, text mining | PubMed |
| HBV Infection-Related PDZK1 Plays an Oncogenic Role by Regulating the PI3K-Akt Pathway and Fatty Acid Metabolism and Enhances Immunosuppression. | J Immunol Res | 2022 | 36052278 | PubTator, text mining | PubMed |
| Identification of PLAUR-related ceRNA and immune prognostic signature for kidney renal clear cell carcinoma. | Front Oncol | 2022 | 36052236 | PubTator, text mining | PubMed |
| IFN-α with dasatinib broadens the immune repertoire in patients with chronic-phase chronic myeloid leukemia. | J Clin Invest | 2022 | 36047494 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3113/papers?page=36